Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 12,000 shares at $66.43 ($791K) on 2021-01-14, disclosed to the SEC on 2021-01-15.
Open-market sale of $791k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.77 | 5,041 | $332K | 41.9% |
| 2 | $65.77 | 5,041 | $332K | 41.9% |
| 3 | $66.43 | 959 | $64K | 8.1% |
| 4 | $66.43 | 959 | $64K | 8.1% |
| Total | $65.88 avg | 12,000 | $791K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |